Clearance of hepatitis C virus after living-donor liver transplantation in spite of residual viremia on end date of interferon therapy before transplantation

Figure 1 Clinical course of the disease at our hospital. The upper diagram showing the course of the virus titter, in which HCV is the core antigen (fmol/L), and expediently negative HCV core antigen is denoted as 20 fmol/L and negative qualitative HCV-RNA as 1 fmol/L. The lower diagram showing the course of total bilirubin and AST. Three small arrows show abdominal operation after LDLT and a large arrow demonstrates LDLT.